Delivery Order SPE2DB24D2013-SPE2DB25FCHKD

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract award to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has a ceiling value of $2,265.90 and a period of performance through February 10, 2025. It is a firm-fixed-price contract type. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of HUMIRA(CF) 40 MG/0.4 ML SYRINGS. It is a firm fixed-price delivery order with a ceiling value of $1,823.76 and an ultimate completion date of June 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of HUMIRA (CF) 40 MG/0.4 ML syringes. The contract has a ceiling value of $24,596.66 and a completion date of June 20, 2024. It is a firm fixed-price contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes, a specialty medication, with a ceiling value of $6,015.10 and a period of performance through January 21, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has a ceiling value of $1,354.57 and is set to expire on April 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has a ceiling value of $51,101.29 and a completion date of December 14, 2023. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of HUMIRA (CF) 40 mg/0.4 ml syringes, a specialty pharmaceutical product. The delivery order has a ceiling value of $2,232.72 and an ultimate completion date of April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) between DLA and...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,246.72, is for the delivery of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is December 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) 40 MG/0.4 ML syringes. The contract has a ceiling value of $2,184.04 and a completion date of May 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary vehicle for the company to...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMIRA(CF) 40 MG/0.4 ML SYRINGES. The contract has a ceiling value of $2,770.74 and a period of performance through October 11, 2024. This contract is not set aside for any particular business size or type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCHKD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide HUMIRA (CF) 40 MG/0.4 ML syringes. The contract is a Firm Fixed Price (FFP) delivery order with a ceiling value of $4,078.80 and a period of performance through February 12, 2025. It is not associated with a set-aside program.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/13/25, 9:57 AM